ORCA Therapeutics
PrivateLast Round
VC Round
Sep 23, 2024
Total Funding Raised
$2.73M
Company Overview
ORCA Therapeutics is a biopharmaceutical company that develops oncolytic virus immunotherapies designed to selectively kill cancer cells and induce an antitumor immune response for cancers such as prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ORCA Therapeutics Comparables
Compare ORCA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lokon Pharma | 85% | |
| TILT Biotherapeutics | 84% | |
| Theolytics | 83% |
ORCA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2024 | ||||
| Grant | May 4, 2016 | ||||
| VC Round | Apr 1, 2016 | ||||
| Debt | Nov 8, 2011 |
ORCA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Oost NL | VC Round |
| Aglaia Oncology Funds | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2024
$2.2M round led by Aglaia Oncology Funds and Oost NL.
- May 4, 2016
Secured $1.27M from the European Commission and Horizon 2020.
ORCA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ORCA Therapeutics's valuation, stock price, and market status.
Is ORCA Therapeutics a public or private company?
ORCA Therapeutics is a private company.
What is the current stock price of ORCA Therapeutics?
ORCA Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ORCA Therapeutics worth (valuation)?
Valuation information for ORCA Therapeutics is not publicly available.
Can I buy ORCA Therapeutics stock?
ORCA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ORCA Therapeutics's last funding round?
ORCA Therapeutics's most recent funding round was VC Round on September 23, 2024.
Who are the main investors in ORCA Therapeutics?
Key investors in ORCA Therapeutics include European Commission.
Will ORCA Therapeutics IPO soon?
No public IPO plans have been announced for ORCA Therapeutics.
How can I track ORCA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ORCA Therapeutics's secondary market activity and sign up for updates.